All News 2cureX AB

Equities

2CUREX

SE0010468124

Delayed Nasdaq Stockholm Other stock markets 12:30:04 15/05/2024 pm IST			5-day change	1st Jan Change
0.399 ^SEK	-0.25%		+18.75%	-80.15%

29/02	2curex AB Elects Grith Hagel as a New Board Member	CI
22/02	2cureX AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

2CUREX AB (PUBL) HAS DECIDED TO APPLY FOR A DELISTING OF ITS SHARES ON NASDAQ FIRST NORTH GROWTH MARKET IN STOCKHOLM – EXPECTED LAST DAY OF TRADING BY END OF JUNE	07/05	AQ
2CUREX AB (PUBL) PROVIDES AN UPDATE ON ITS FINANCIAL POSITION AND CURRENT OPERATIONS	16/03	AQ
BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING IN 2CUREX AB (PUBL)	29/02	AQ
2curex AB Elects Grith Hagel as a New Board Member	29/02	CI
2CUREX PUBLISHES INTERIM REPORT FOR THE FOURTH QUARTER AND FULL YEAR OF 2023 AND FINANCIAL AND STRATEGIC OUTLOOK FOR 2024	22/02	AQ
2cureX AB Reports Earnings Results for the Full Year Ended December 31, 2023	22/02	CI
2cureX AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	22/02	CI
NOTICE TO ATTEND THE EXTRAORDINARY GENERAL MEETING OF 2CUREX AB (PUBL)	12/02	AQ
2cureX AB Announces Change to the Board of Directors	04/01	CI
2cureX AB Announces CEO Changes	29/12	CI
2cureX AB Announces Executive Changes, Effective 1 January 2024	29/12	CI
2cureX Makes Executive Changes Amid Planned Global Expansion of IndiTreat Tests; Shares Drop	29/12	MT
2cureX AB Receives Ethical Approval for HIPEC Clinical Trial	06/12	CI
2cureX publishes interim report for the third quarter of 2023	23/11	AQ
2cureX AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23/11	CI
BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING IN 2CUREX AB (PUBL)	14/11	AQ
2Curex AB Appoints Tonni Bülow-Nielsen as Board Member and Chairman	14/11	CI
Transcript : 2cureX AB, Q3 2023 Earnings Call, Oct 26, 2023	26/23/26
2cureX Announces to Focus All Resources on Making IndiTreat Testing Available at Hospitals Worldwide by Accelerating the Development of an Automated IVD System	26/23/26	CI
NOTICE TO ATTEND THE EXTRAORDINARY GENERAL MEETING OF 2CUREX AB (PUBL)	25/23/25	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News 2cureX AB

Equities

2CUREX

SE0010468124

All News

Filters